Creso Pharma

Perth, Australia Founded: 2015 • Age: 11 yrs Listed Acquired By PharmaCielo
Cannabinoid therapeutics are developed for human and veterinary health applications.

About Creso Pharma

Creso Pharma is a Healthcare company based in Perth (Australia) founded in 2015, and was acquired by PharmaCielo in June 2019. Cannabinoid therapeutics are developed for human and veterinary health applications. Creso Pharma has completed 4 acquisitions, including Halucenex, Health House International and Mernova. Its chief executive, as recorded, is Marc Lustig. Its focus areas include HealthTech, Veterinary HealthTech, Health Supplements and Cannabinoid.

Company details

Creso Pharma was founded in 2015 and is headquartered in Perth, Australia. Operations focus on the biotechnology sector, where cannabinoid therapeutics are developed using nanotechnology for both human and veterinary uses. Lead products include a cannabidiol hemp oil-based complementary feed for companion animals and a nutraceutical targeted at human health. The company addresses multiple health purposes through these formulations.

Key Metrics

Funding Insights of Creso Pharma

  • Total Rounds 5
  • First Round $5.6M

    (Mar 2017)

  • Investors Count 1

All 5 funding rounds of Creso Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2020Post-IPO––
–
Jun 2020$1.42MPost-IPO––
–
Jan 2019$3MPost-IPO––
–
Nov 2017$17.5MPost-IPO––
–
Mar 2017$5.6MPost-IPO––
Valuation history

2 investors in total: 2 institutional.

Investors in Creso Pharma

Creso Pharma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include PharmaCielo and EverBlu Capital.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
everblucapital.com
Medicinal cannabis oil and products are produced in Colombia.
2014pharmacielo.comToronto, Canada
Premium access

Investor details for Creso Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Creso Pharma

1 people are tracked at Creso Pharma (1 in leadership).

NameRoleGroup
Marc Lustig
CEOLeadership
Premium access

Complete people profiles for Creso Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Creso Pharma

Creso Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Halucenex, Health House International and Mernova.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Cannabis medical services are provided to patients in Australia.
healthhouse.com.auPerth, Australia2014May 2023β€’β€’β€’β€’
Contract manufacturing of plant-based skin care products is provided.
sierrasageherbs.comLyons, United States2008Feb 2022$21M
Psychedelic drugs for mental illness treatment are developed by Halucenex.
halucenex.comWindsor, Canada2019Mar 2021β€’β€’β€’β€’
Cannabis is produced and supplied by Mernova in Canada.
mernova.comCanada2014Jun 2017β€’β€’β€’β€’
Premium access

Complete acquisition details for Creso Pharma

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Creso Pharma

9 dated milestones of Creso Pharma across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Creso Pharma is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $5.6M.
  4. Acquisition Acquires Mernova.
  5. Exit Acquired by PharmaCielo.
  6. Funding Latest funding round, Post-IPO,.
  7. Acquisition Acquires Halucenex.
  8. Acquisition Acquires Sierra Sage.
  9. Acquisition Acquires Health House International.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Creso Pharma

Premium access

Complete news archive for Creso Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Creso Pharma

Creso Pharma was founded in 2015 and raised its 1st funding round 2 years after it was founded.

Creso Pharma is headquartered in Perth, Australia. It is registered at Perth, Western Australia, Australia.

Marc Lustig is the CEO of Creso Pharma, as recorded in our data.

Creso Pharma was founded in 2015 and is headquartered in Perth, Australia. Operations focus on the biotechnology sector, where cannabinoid therapeutics are developed using nanotechnology for both human and veterinary uses. Lead products include a cannabidiol hemp oil-based complementary feed for companion animals and a nutraceutical targeted at human health. The company addresses multiple health purposes through these formulations.

Creso Pharma has made 4 acquisitions, including Halucenex, Health House International, and Mernova.

Creso Pharma has 2 investors. Key investors include PharmaCielo, and EverBlu Capital.

Yes. Creso Pharma was acquired by PharmaCielo in June 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available